Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?

Background: To evaluate the effects of a 24/4 regimen combined oral contraceptive (COC) containing 1.5 mg 17β-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) compared to on-demand nonsteroidal anti-inflammatory drugs (NSAIDs) on women affected by endometriosis-associated chronic pelvic pain (t...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Salvatore, Cianci, Antonio, Iraci, Marco, Fava, Valentina, Di Pasqua, Salvatore, Cianci, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520912/
https://www.ncbi.nlm.nih.gov/pubmed/32678691
http://dx.doi.org/10.1089/jwh.2020.8291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520912/
https://www.ncbi.nlm.nih.gov/pubmed/32678691
http://dx.doi.org/10.1089/jwh.2020.8291

Ejemplares similares